52 results
8-K
EX-10.2
KA
Kineta Inc
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
) the reputation of the Company or any of the Released Parties. A breach of this provision will be deemed to be a material breach of this Agreement
8-K
EX-10.1
KA
Kineta Inc
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
or prospects) or (b) the reputation of the Company or any of the Released Parties. A breach of this provision will be deemed to be a material breach
8-K
EX-99.5
KA
Kineta Inc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
, resulting in damage to Kineta’s reputation and business.
Kineta relies on third parties to conduct, supervise and monitor its clinical trials and perform … the market after obtaining marketing approval;
be subject to lawsuits; or
experience damage to Kineta’s reputation.
Conducting clinical trials
8-K/A
EX-99.1
KA
Kineta Inc
3 Feb 21
Other Events
4:59pm
exposed to or taking its products;
the product may become less competitive; and
its reputation may suffer.
Any of these events could prevent Yumanity … harm to its reputation. Yumanity has adopted a code of business conduct and ethics, but it is not always possible to identify and deter misconduct
10-Q
4ejmu4wqxfa4nx2eb 0i
13 May 16
Quarterly report
12:00am